Filter by tags

Why root-only ashwagandha matters: what the classical texts and modern research agree on

Key Takeaways

  • Ayurvedic classical texts were specific about which part of the ashwagandha plant was therapeutically active. The leaves and stems had separate, different uses.
  • The root contains the highest concentration of withanolides, the steroidal lactone compounds that are the primary bioactive candidates for ashwagandha's adaptogenic effects.
  • KSM-66 is a full-spectrum root extract standardized to a minimum of 5% withanolides, produced using a water and milk-based extraction process with no harsh chemical solvents.
  • Over 24 clinical trials have been conducted specifically on KSM-66, showing consistent results for cortisol reduction, stress resilience, sleep, physical performance, and cognition.
  • Whole-plant and leaf-heavy extracts are cheaper to produce but have a different bioactive profile and are not backed by the same body of clinical evidence.
Why root-only ashwagandha matters: what the classical texts and modern research agree on

Ashwagandha has had quite a moment in the British wellness market. In the space of a few years it has gone from being a word most people could not pronounce to an ingredient in everything from sleep supplements to pre-workout formulas to supermarket own-brand stress gummies. Which is, on balance, a good thing except that the popularity of the name has outpaced any real understanding of what makes ashwagandha effective, and why the ashwagandha in one product might be genuinely different from the ashwagandha in another.

KSM-66 Ashwagandha Honey Sticks use a root-only extract and specifically KSM-66, the form of ashwagandha that has been studied in more clinical trials than any other extract. That is not a detail buried in small print. That is the whole point. Here is why root specificity matters, where the evidence comes from, and what three thousand years of Ayurvedic tradition and modern randomised controlled trials turn out to agree on.


What the classical texts actually said and why root specificity was never arbitrary

Ashwagandha (Withania somnifera) has been a cornerstone of Ayurvedic medicine for over three thousand years. Its name translates from Sanskrit as "smell of horse" capturing both the root's distinctive earthy aroma and the traditional association with the stamina, strength, and vitality of horses. It occupies a prominent place in the Rasayana category: substances that support systemic rejuvenation, longevity, and the restoration of ojas, the foundational vital energy that underlies physical and mental resilience.

The Charaka Samhita and Sushruta Samhita the two foundational classical texts of Ayurvedic medicine, compiled over two thousand years ago were not vague about which part of the ashwagandha plant they were describing. The root is what the Rasayana context refers to. The leaves were used for different preparatory and topical applications. The stem had other uses. This was not imprecision. Ayurvedic physicians were methodical empirical observers who documented treatment protocols across centuries of practice. The root specificity was a considered clinical distinction based on observed outcomes.

Modern phytochemistry has since explained exactly why they were right.


The plant chemistry that explains three thousand years of clinical observation

Ashwagandha's primary bioactive compounds are withanolides steroidal lactones that occur in their highest concentrations in the root. Withanolides are the main compounds researchers have focused on in studying ashwagandha's adaptogenic, anti-inflammatory, and neuroprotective properties. They are the basis for standardisation: when a label says "standardised to 5% withanolides," it means the extract guarantees a minimum concentration of these specific compounds per serving.

The root also contains alkaloids, iron, and a broader phytochemical complex that contributes to the full-spectrum bioactive profile. The leaves have a different withanolide composition notably higher in withaferin A, which has distinct biological activity and a different overall phytochemical profile. When a supplement is made from whole-plant ashwagandha (root, leaves, stem), the withanolide concentration per gram drops and the proportion of leaf-derived compounds increases. The resulting extract is not equivalent to root extract, does not reflect the bioactive profile the classical texts were working with, and is not what the major clinical trials have studied.

It is, however, considerably cheaper to produce which is why it is so common.


What KSM-66 is, and why the extraction process is part of the quality story

KSM-66 is a trademarked, full-spectrum root extract of Withania somnifera, developed by Ixoreal Biomed. Full-spectrum means the natural ratio of compounds present in the root is preserved, rather than isolating a single withanolide fraction. It is standardized to a minimum of 5% withanolides a consistently defined concentration guaranteed in every batch.

What sets KSM-66's production apart from most botanical extract manufacturing is the extraction process. The majority of high-potency plant extracts are produced using alcohol or other chemical solvents to concentrate active compounds. KSM-66 uses a water and milk-based extraction method specifically engineered to avoid harsh solvents and to align with the traditional Ayurvedic preparation of ashwagandha root in milk or ghee. This alignment is not simply cultural sensitivity. Some of ashwagandha's bioactive compounds are lipophilic (fat-soluble), and traditional milk-based preparations likely supported their absorption in ways that aqueous extraction alone does not replicate. The KSM-66 process is designed to preserve this advantage while meeting contemporary manufacturing standards.

KSM-66 holds GRAS status and has been the specific form used in over 24 clinical trials. Third-party testing for withanolide content, purity, and heavy metal safety on every production batch is a non-negotiable part of the specification.


What the randomised controlled trials actually show

The clinical evidence on KSM-66 is what makes the root-only, standardised extract story more than a quality argument; it is also an efficacy argument.

A 2012 randomised controlled trial published in the Indian Journal of Psychological Medicine found that 300mg of KSM-66 twice daily over 60 days produced significant reductions in serum cortisol and self-reported stress scores, alongside improvements in sleep quality and general wellbeing, compared to placebo. This is the cortisol normalisation mechanism KSM-66 working on the HPA axis to reduce the chronic cortisol elevation that underlies stress-related fatigue, sleep disruption, and the hormonal suppression that stress produces downstream.

A 2019 trial published in Medicine found that KSM-66 supplementation in resistance-training men was associated with significantly greater increases in muscle strength, recovery, and testosterone levels alongside cortisol reductions. Research in the Journal of the International Society of Sports Nutrition found improvements in cardiorespiratory endurance and VO2 max. Studies in the Journal of Dietary Supplements found improvements in memory, executive function, and information-processing speed.

These effects stress resilience, sleep quality, physical performance, cognitive function map directly to what the Charaka Samhita described as the outcomes of ashwagandha Rasayana treatment. Three thousand years apart, the conclusion is the same.


The honey stick delivery and why it echoes classical preparation

Ashwagandha root is not inherently pleasant to eat. Its earthy, bitter flavour is distinctive enough that Ayurvedic preparations consistently combined it with honey, ghee, or milk substances that made it palatable and, particularly in the case of fats, may have supported the absorption of lipophilic compounds. Our KSM-66 Ashwagandha Honey Sticks deliver the root extract in raw honey, the closest contemporary equivalent to the classical preparation, in a single-serve format that requires no measuring, no capsules, and no dissolving in lukewarm water that tastes of nothing good.

GMP-certified. FSA-compliant. Third-party tested for withanolide content, purity, and heavy metal safety on every production batch. No artificial additives.

Frequently Asked Questions

The therapeutic use of ashwagandha documented in Ayurvedic texts and studied in clinical trials is based on the root. The root contains the highest withanolide concentration and the specific bioactive profile that the adaptogenic and HPA axis-modulating research is built around. Whole-plant extracts dilute this profile with leaf-derived compounds that have different biological activity. The distinction determines whether you are getting what the evidence supports or simply a product that carries the ashwagandha name.

Clinical trials typically show meaningful results at eight to twelve weeks of consistent daily use, with stress and sleep improvements tending to appear earliest at four to six weeks. Ashwagandha is an adaptation whose effects build gradually as the HPA axis normalises and cortisol patterns shift, rather than producing immediate acute changes. The analogy is not a painkiller. It is more like gradually turning down a dial that has been turned up too high for too long.

Both are proprietary, standardised ashwagandha extracts with clinical research behind them. KSM-66 is root-only, standardized to 5% withanolides, and has more total published trials. Sensoril uses both root and leaf, is standardized to a combination of withanolides and withanosides, and tends to be used at lower doses due to its higher concentration. They are not interchangeable; the bioactive profiles differ, the dosing differs, and the specific trial outcomes differ. KSM-66 is the better-studied option for stress, sleep, and performance outcomes.